NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Fernández Velasco, María ^a,b   Prieto, Patricia ^b   Terrón, Verónica ^b   Benito, Gemma ^a   Flores, Juana M ^c   Delgado, Carmen ^c,d   Zaragoza, Carlos ^e   Lavin, Begoña ^e   Gómez Parrizas, Mónica ^e   López Collazo, Eduardo ^a   Martín Sanz, Paloma ^a,b,f   Boscá, Lisardo ^a,b,f  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 4; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DOWN REGULATION; FIBROBLAST; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; INFLAMMATION; INNATE IMMUNITY; M MODE ECHOCARDIOGRAPHY; MOUSE; NONHUMAN; PATHOGENESIS; PATTERN RECOGNITION; PROTEIN EXPRESSION; RAT; TISSUE INJURY;

ANIMALS; APOPTOSIS; BIOLOGICAL FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMYOCARDIAL FIBROSIS; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART FAILURE; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; NOD1 SIGNALING ADAPTOR PROTEIN; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MURINAE;

EID: 84866521651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045260     Document Type: Article

References (46)

1. Ting JP, Duncan JA, Lei Y, (2010) How the noninflammasome NLRs function in the innate immune system. Science 327: 286-290.
2. Linde A, Mosier D, Blecha F, Melgarejo T, (2007) Innate immunity and inflammation: New frontiers in comparative cardiovascular pathology. Cardiovasc Res 73: 26-36.
3. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
4. Xu XH, Shah PK, Faure E, Equils O, Thomas L, et al. (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104: 3103-3108.
5. Wong FS, Hu C, Zhang L, Du W, Alexopoulou L, et al. (2008) The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann N Y Acad Sci 1150: 146-148.
6. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ, (2002) Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105: 1158-1161.
7. Libby P, Ridker PM, Hansson GK, (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54: 2129-2138.
8. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, et al. (1999) Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104: 271-280.
9. Birks EJ, Felkin LE, Banner NR, Khaghani A, Barton PJ, et al. (2004) Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. J Heart Lung Transplant 23: 228-235.
10. Meylan E, Tschopp J, Karin M, (2006) Intracellular pattern recognition receptors in the host response. Nature 442: 39-44.
11. Kanneganti TD, Lamkanfi M, Nunez G, (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549-559.
12. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE, (2006) Nod-like proteins in immunity, inflammation and disease. Nat Immunol 7: 1250-1257.
13. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278: 5509-5512.
14. da Silva Correia J, Miranda Y, Austin-Brown N, Hsu J, Mathison J, et al. (2006) Nod1-dependent control of tumor growth. Proc Natl Acad Sci USA 103: 1840-1845.
15. da Silva Correia J, Miranda Y, Leonard N, Hsu J, Ulevitch RJ, (2007) Regulation of Nod1-mediated signaling pathways. Cell Death Differ 14: 830-839.
16. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, et al. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4: 702-707.
17. Inohara N, Chamaillard M, McDonald C, Nunez G, (2005) NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 74: 355-383.
18. Uehara A, Fujimoto Y, Fukase K, Takada H, (2007) Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44: 3100-3111.
19. Masumoto J, Yang K, Varambally S, Hasegawa M, Tomlins SA, et al. (2006) Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 203: 203-213.
20. Travassos LH, Carneiro LA, Girardin S, Philpott DJ, (2010) Nod proteins link bacterial sensing and autophagy. Autophagy 6: 409-411.
21. Cartwright N, Murch O, McMaster SK, Paul-Clark MJ, van Heel DA, et al. (2007) Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am J Respir Crit Care Med 175: 595-603.
22. Kvarnhammar AM, Petterson T, Cardell LO, (2011) NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists. Immunology 134: 314-325.
23. Fernandez-Velasco M, Rueda A, Rizzi N, Benitah JP, Colombi B, et al. (2009) Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res 104: 201-209.
24. Camelliti P, Borg TK, Kohl P, (2005) Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65: 40-51.
25. Goldsmith EC, Hoffman A, Morales MO, Potts JD, Price RL, et al. (2004) Organization of fibroblasts in the heart. Dev Dyn 230: 787-794.
26. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G, (2001) Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 276: 2551-2554.
27. Lee KY, Ito K, Hayashi R, Jazrawi EP, Barnes PJ, et al. (2006) NF-κB and activator protein 1 response elements and the role of histone modifications in IL-1β-induced TGF-β1 gene transcription. J Immunol 176: 603-615.
28. Schmierer B, Hill CS, (2007) TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8: 970-982.
29. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, et al. (1999) Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J Biol Chem 274: 14560-14567.
30. Souders CA, Bowers SL, Baudino TA, (2009) Cardiac fibroblast: the renaissance cell. Circ Res 105: 1164-1176.
31. Burstein B, Nattel S, (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51: 802-809.
32. Frantz S, Ertl G, Bauersachs J, (2007) Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 4: 444-454.
33. Li C, Browder W, Kao RL, (1999) Early activation of transcription factor NF-κB during ischemia in perfused rat heart. Am J Physiol 276: H543-552.
34. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, et al. (1997) In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3: 894-899.
35. Li C, Ha T, Kelley J, Gao X, Qiu Y, et al. (2004) Modulating Toll-like receptor mediated signaling by (1->3)-β-D-glucan rapidly induces cardioprotection. Cardiovasc Res 61: 538-547.
36. Hua F, Ha T, Ma J, Li Y, Kelley J, et al. (2007) Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 178: 7317-7324.
37. Nishio H, Kanno S, Onoyama S, Ikeda K, Tanaka T, et al. (2011) Nod1 ligands induce site-specific vascular inflammation. Arterioscler Thromb Vasc Biol 31: 1093-1099.
38. Moreno L, McMaster SK, Gatheral T, Bailey LK, Harrington LS, et al. (2010) Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophages. Br J Pharmacol 160: 1997-2007.
39. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
40. Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, et al. (2005) NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 14: 935-941.
41. Weidinger S, Klopp N, Rummler L, Wagenpfeil S, Novak N, et al. (2005) Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 116: 177-184.
42. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, et al. (2001) CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep 2: 736-742.
43. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, et al. (2007) Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 179: 514-521.
44. Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, et al. (2009) XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A 106: 14524-14529.
45. Khan R, Sheppard R, (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-β in cardiomyopathy, valvular disease and arrhythmia. Immunology 118: 10-24.
46. Woessner JF Jr, (1998) Role of matrix proteases in processing enamel proteins. Connect Tissue Res 39: 69-73.